Malignant melanoma in children: A review

Archives of Dermatology

Volumn 133, Issue 3, 1997, Pages 363-368

  Ruiz Maldonado, Ramon ^a,b   De La Luz Orozco Covarrubias, Ma ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMELANOTIC MELANOMA; CANCER INCIDENCE; CLINICAL FEATURE; CONGENITAL CANCER; DIFFERENTIAL DIAGNOSIS; DYSPLASTIC NEVUS; HUMAN; LYMPH NODE METASTASIS; MELANOCYTIC NEVUS; MELANOMA; OTA NEVUS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SKIN CANCER;

EID: 0030948519     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.1997.03890390103014     Document Type: Review

References (133)

1. Houghton A, Flannery J, Viola MV. Malignant melanoma in Connecticut and Denmark. Int J Cancer. 1980;25:95-104.
2. Osterlind A. Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol. 1990;29:833-854.
3. Akslen LA. Etiological and pathological aspects of malignant melanoma. Tidsskr Nor Laegeforen. 1994;114:908-911.
4. Austoker J. Melanoma: prevention and early diagnosis. BMJ. 1994;308:1682-1686.
5. Jeifs PL, Giles G, Shugg D, et al. Cutaneous malignant melanoma in Australia, 1989. Med J Aust. 1994;161:182-187.
6. Koh HK. Cutaneous melanoma. N Engl J Med. 1992;325:171-182.
7. National Cancer Institute. Annual Cancer Statistics Review, Including Cancer Trends, 1950-1985. Washington, DC: US Dept of Health and Human Services; 1988. NIH publication 88-2789.
8. Williams M, Pennella R. Melanoma, melanocytlc nevi, and other melanoma risk factors in children. J Pediatr. 1994;124:833-845.
9. Boddie AW Jr, Smith JL, McBride CM. Malignant melanomas in children and young adults: effect of diagnostic criteria on staging and end results. South Med J. 1978;71:1074-1078.
10. Myhre E. Malignant melanomas in children. Acta Pathol Microbiol Scand. 1963;59:184-188.
11. Bader JL, Li FP, Olmstead PM, Strickman NA, Green DM. Childhood malignant melanoma: incidence and etiology. Am J Pediatr Hematol Oncol. 1985;7:341-345.
12. Moss ALH, Briggs JC. Cutaneous malignant melanoma in the young. Br J Plast Surg. 1986;39:537-541.
13. Temple WJ, Mulloy RH, Alexander F, Marx LH, Jenkins M, Jerry LM. Childhood melanoma. J Pediatr Surg. 1991;267:135-137.
14. Tate PS, Ronan SG, Feucht KA, Eng AM, Das Gupta TK. Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg. 1993;28:217-222.
15. McWhirter WR, Dobson C. Childhood melanoma in Australia. World J Surg. 1995;19:334-336.
16. Pratt CB, Palmer MK, Thatcher N, Crowther D. Malignant melanoma in children and adolescents. Cancer. 1981;47:392-397.
17. Rao BN, Hayes FA, Pratt CB, et al. Malignant melanoma in children: its management and prognosis. J Pediatr Surg. 1990;25:198-203.
18. Skov-Jensen I, Hastrup J, Lambrethsen E. Malignant melanoma in children. Cancer. 1966;19:620-626.
19. Mehregan AH, Mehregan DA. Malignant melanoma in childhood. Cancer. 1993;71:4096-4103.
20. Holland E. A case of transplacental metastasis of malignant melanoma from mother to fetus. Obstet Gynaecol Br Empire. 1949;56:529-536.
21. Dargeon HW, Eversole JW, DelDuca V. Malignant melanoma in an infant. Cancer. 1950;3:299-306.
22. Cavell B. Transplacental metastasis of malignant melanoma. Acta Paediatr Suppl. 1963;146:37-40.
23. Potter JF, Schoeneman M. Metastasis of maternal cancer to the placenta and fetus. Cancer. 1970;25:380-388.
24. Brodsky I, Baren M, Kahn SB, Lewis G Jr, Tellem M. Metastatic malignant melanoma from mother to fetus. Cancer. 1965;18:1048-1054.
25. Cannon-Albright LA, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science. 1992;258:1148-1152.
26. Stephenson HE Jr, Terry CW, Lukens JN, et al. Immunologic factors in human melanoma 'metastatic' to products of gestation (with exchange transfusion of infant to mother). Surgery. 1971;69:515-522.
27. Aronsson S. A case of transplacental tumor metastasis. Acta Paediatr. 1963;52:123-124.
28. Truax KF, Page HG. Prepubertal malignant melanoma. Ann Surg. 1953;137:255-260.
29. Stromberg BV. Malignant melanoma in children. Pediatr Surg. 1979;14:465-467.
30. Oldhoff J, Koudstaal J. Congenital papillomatous malignant melanoma of the skin. Cancer. 1968;21:1193-1197.
31. Hayes FA, Green AA. Malignant melanoma in childhood: clinical course and response to chemotherapy. J Clin Oncol. 1984;2:1229-1234.
32. Sweet LK, Connerty HV. Congenital melanoma: report of a case in which antenatal metastasis occurred. AJDC. 1951;62:1029-1040.
33. Schneiderman H, Wu AY, Campbell WA. Congenital melanoma with multiple prenatal metastases. Cancer, 1987;60:1371-1377.
34. Kadonaga JN, Frieden U. Neurocutaneous melanosis: definition and review of the literature. J Am Acad Dermatol. 1991;24:747-755.
35. Pascual-Castroviejo I. Neurocutaneous melanosis. In: Rodriguez-Gomez M, ed. Neurocutaneous Diseases: A Practical Approach. Newton, Mass: Butterworth-Heinemann; 1987:329-334.
36. Frieden IJ, Williams ML, Barkovich AJ. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol. 1994;31:423-429.
37. Melnik MK, Urdaneta LF, Al-Jurf AS, et al. Malignant melanoma in childhood and adolescence. Am Surg. 1986;52:142-147.
38. Orozco-Covarrubias ML, Tamayo L, Duran C, Ridaura C, Ruiz-Maldonado R. Malignant cutaneous tumors in children: twenty years of experience at a large pediatric hospital. J Am Acad Dermatol. 1994;30:243-249.
39. Kibbi AG, Mihm MC, Sober AJ, et al. Diagnosis and management of malignant melanoma. Compr Ther. 1986;12:23-31.
40. Lee S, Skin cancer. In: Ruiz-Maldonado R, Parish L, Beare M, eds. Textbook of Pediatric Dermatology. New York, NY: Grune & Stratton Inc; 1989:756-766.
41. Handfield-Jones SE, Smith NP. Malignant melanoma in childhood. Br J Dermatol. 1996;134:607-616.
42. Ghorbani Z, Dowlati Y, Mehregan A. Amelanotlc spitzoid melanoma in the burn scar of a child. Pediatr Dermatol. 1996;13:285-287.
43. Fisher SR, Reintgen DS, Seigler HF. Juvenile malignant melanoma of the head and neck. Laryngoscope. 1988;98:184-189.
44. Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol. 1979;1:123-129.
45. Castilla EE, de Graca M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi, I: incidence rates and relative frequencies. Br J Dermatol. 1981;104:307-315.
46. The management of congenital nevocytic nevi. Pediatr Dermatol. 1984;2:143-156.
47. Gari LM, Rivers JK, Kopf AW. Melanomas arising in large congenital nevocytic nevi: a prospective study. Pediatr Dermatol. 1988;5:151-158.
48. Rhodes AR, Wood WC, Sober AJ, Mihm MC. Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg. 1981;67:782-790.
49. Ruiz-Maldonado R, Tamayo L, Laterza AM, Duran C. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992;120:906-911.
50. Marghoob AA, Schoenbach SP, Kopf AW, Orlow SJ, Nossa R, Bart RS. Large congenital melanocytic nevi and the risk for the development of malignant melanoma: a prospective study. Arch Dermatol. 1996;132:170-175.
51. Swerdlow AJ, English JSC, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol. 1995;32:595-599.
52. Quaba AA, Wallace AF. The incidence of malignant melanoma (0 to 15 years of age) arising in 'large' congenital nevocellular nevi. Plast Reconstr Surg. 1986;78:174-181.
53. Arons MS, Hurwitz S. Congenital nevoceliular nevus: a review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg. 1983;72:355-365.
54. Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol. 1976;95:389-396.
55. Kroon S, Clemmensen OJ, Hastrup N. Incidence of congenital melanocytic nevi in newborn babies in Denmark. J Am Acad Dermatol. 1987;17:422-426.
56. Hidano A, Purwoko R, Jitsukawa K. Statistical survey of skin changes in Japanese neonates. Pediatr Dermatol. 1986;3:140-144.
57. Rhodes AR, Sober AJ, Day CL, et al. The malignant potential of small congenital nevoceliular nevi. J Am Acad Dermatol. 1982;6:230-241.
58. Rhodes AR, Melsk JW. Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr. 1982;100:219-224.
59. Alper JC. Congenital nevi: the controversy rages on. Arch Dermatol. 1985;121:734-735.
60. Illig L. Weidner F, Hundeiker M, et al. Congenital nevi less than or equal to 10 cm as precursors to melanoma. Arch Dermatol. 1985;121:1274-1281.
61. Boddie AW, McBride CM. Melanoma in childhood and adolescence. In: Balch CM, Milton GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia, Pa: JB Lippincott; 1985:63-70.
62. Kaplan EN. The risk of malignancy in large congenital nevi. Plast Reconstr Surg. 1974;53:421-428.
63. Solomon LM. The management of congenital melanocytic nevi. Arch Dermatol. 1980;116:1017.
64. From L. Congenital nevi: let's be practical. Pediatr Dermatol. 1992;9:345-346.
65. Clemmensen O, Ackerman AB. All small congenital nevi need not be removed. Am J Dermatopathol. 1979;6:189-194.
66. Tucker MA, Greene MH, Clark WH Jr, Kraemer KH, Fraser MC, Elder DE. Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr. 1983;103:65-69.
67. Greene MH. Dysplastic nevus syndrome. Hosp Pract (Off Ed). 1984;19:91-108.
68. Kraemer K. Dysplastic nevi as precursors to hereditary melanoma. J Dermatol Surg Oncol. 1983;9:619-622.
69. Kraemer KH, Greene MH. Dysplastic nevus syndrome: familial and sporadic precursors of cutaneous melanoma. Dermatol Clin. 1985;3:225-237.
70. Ceballos P, Ruiz-Maldonado R, Mihm M. Melanoma in children. N Engl J Med. 1995;332:656-662.
71. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions: the 'B-K mole' syndrome. Arch Dermatol. 1978;114:732-738.
72. Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fraser MC. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med. 1985;102:458-465.
73. Lerman RI, Murray D, O'Hara JM, Booher RJ, Foote FW Jr. Malignant melanoma in childhood: a clinicopathologic study and a report of 12 cases. Cancer. 1970;25:436-449.
74. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus: case report and literature review. J Am Acad Dermatol. 1988;19:712-722.
75. Borrego L, Hernandez Santana J, Baez O, Hermandez Hernandez B. Naevus spilus as a precursor of cutaneous melanoma: report of a case and literature review. Clin Exp Dermatol. 1994;19:515-517.
76. Theunissen P, Spincemaille G, Pannebakker M, Lambers J. Meningeal melanoma associated with nevus of Ota: case report and review. Clin Neuropathol. 1993;12:125-129.
77. Kopf AW, Kripke ML, Stern RS. Sun and malignant melanoma. J Am Acad Dermatol. 1984;11:674-684.
78. Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma: the Importance of UV-light exposure. Int J Cancer. 1988;42:319-324.
79. Koh HK, Kligler BE, Lew RA. Sunlight and cutaneous malignant melanoma: evidence for and against causation. Photochem Photobiol. 1990;17:1050-1053.
80. Weinstock MA, Colditz GA, Willett WC, et al. Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics. 1989;84:199-204.
81. Holly EA, Kelly JW, Shpall SN, Chiu SH. Number of metenocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987;17: 459-468.
82. Zanetti R, Franceschi S, Rosso S, Colonna S, Bidoli E. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer. 1992;28:1172-1176.
83. Movshovitz M, Modan B. Role of sun exposure in the etiology of malignant melanoma: epidemiologic inference. J Natl Cancer Inst. 1973;51:777-779.
84. Holman CD, Mulroney CD, Armstrong BK. Epidemiology of preinvasive and invasive malignant melanoma in Western Australia. Int J Cancer. 1980;25:317-323.
85. Rivers JK, MacLennan R, Kelly JW, et al. The Eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol. 1995;32:957-963.
86. Lookingbill DP, Lookingbill GL, Leppard B. Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an out-reach skin care program. J Am Acad Dermatol. 1995;32:653-658.
87. Holman CDJ, Armstrong BD. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst. 1984;72:257-266.
88. Beral V, Evans S, Shaw H, et al. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983;109:165-172.
89. Elwood JM, Gallagher RP, Hill GB, Spinelli JJ, Pearson JCG, Threlfall W. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ. 1984;21:1-10.
90. Osterlind A, Tucker MA, Hou-Jensen K. The Danish case-control study of cutaneous malignant melanoma, I: importance of host factors. Int J Cancer. 1986;42:200-206.
91. Goldstein AM, Dracopoli NC, Engelstein M, Fraser MC, Clark WH Jr, Tucker MA. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet. 1994;54:489-496.
92. O'Broin ES, McDermott M, Sweeney EC, Tait R, Tanner WA. Malignant melanoma in a 7-year-old child. Pediatr Surg Int. 1995;10:202-204.
93. Anderson D, Smith JL Jr, McBride CM. Hereditary aspects of malignant melanoma. JAMA. 1967;200:741-746.
94. Novakovick B, Clark WH Jr, Fears TR, Fraser MC, Tucker MA. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanomaprone families. J Am Acad Dermatol. 1995;33:631-636.
95. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987;123:241-250.
96. Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum: an inherited disease with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974;80:221-248.
97. Greene MH, Fraumeni JF. The hereditary variant of malignant melanoma. In: Clark WH Jr, Goldman LI, Mastrangelo MJ, eds. Human Malignant Melanoma. New York, NY: Grune & Stratton Inc; 1979:139-166.
98. Bystryn JC. The immunobiology of human malignant melanoma. Int J Dermatol. 1980;19:375-378.
99. Tucker MA, Mlsfeldt D, Cotoman N, Clark WH Jr, Rosenberg SA. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med. 1985;102:37-41.
100. Shell AGR, Flavel S, Disney APS, et al. Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc. 1985;17:1685-1688.
101. Duvic M, Lowe L, Rapini RP, Rodrigue: S, Levy ML. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol. 1989;125:397-401.
102. Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ. 1989;299:88-91.
103. Baird EA, McHenry PM, Mackie RM. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. BMJ. 1992;305:799-801.
104. De Wit PEJ, de Vaan GAM, de Boo TM, Lemmens WAJG, Rampen FHJ. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Pediatr Oncol. 1990;18:336-338.
105. Green A, Smith P, McWhorter W, et al. Melanocytic naevi and melanoma in survivors of childhood cancer. Br J Cancer. 1993;67:1053-1057.
106. Smith CH, McGregor JM, Barker JNWN, Morris RW, Rigden SPA, MacDonald DM. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol. 1993;28:51-55.
107. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal-transplant recipients. Lancet. 1981;1:196-199.
108. Di Saia PJ, Creasman WT. Invasive cancer of the vulva. In: Di Saia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. St Louis, Mo: Mosby-Year Book Inc; 1993:238-272.
109. Fried man RJ, Kopf AW, Jones WB. Malignant melanoma in association with lichen sclerosus on the vulva of a 14-year-old. Am J Dermatopathol. 1984;6:253-256.
110. Ariel IM. Moles and malignant melanoma in the preadolescent child. In: Ariel IM, ed. Malignant Melanoma. New York, NY: Appleton-Century-Crofts; 1981:103.
111. Milton GW, Balch CM, Shaw HM. The primary melanoma: clinical characteristic. In: Balch CM, Mitton GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia, Pa: JB Lippincott; 1985:13-26.
112. Sober AJ. The changing mole. JAMA. 1985;253:1612-1613.
113. Spitz S. Classics in oncology: melanomas of childhood. CA Cancer J Clin. 1991;41:40-51.
114. Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer. 1995;76:1833-1845.
115. Smith KJ, Barrett TL, Skelton HG III, Lupton GP, Graham JH. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13:931-939.
116. Cristofolini M, Zumiani G, Bauer P, Cristofolini P, Boi S, Micciolo R. Dermatoscopy: usefulness in the differential diagnosis of cutaneous pigmentary lesions. Melanoma Res. 1994;4:391-394.
117. Trozak DJ, Rowland WD, Hu F. Meta static malignant melanoma in prepubertal children. Pediatr Clin. 1975;55:191-204.
118. Davidoff A, Cirrincione C, Seigler H. Malignant melanoma in children. Ann Surg Oncol. 1994;1:278-282.
119. Johnson T, Smith J, Nelson B, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol. 1995;32:689-707.
120. Baas PC, Hoekstra HJ, Schraffordt KH, Oosterhuis WJ, van der Weele LT. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents. Cancer. 1989;63:199-203.
121. Hafstrom L, Rudenstam CM, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J Clin Oncol. 1991;9:2091-2094.
122. Falkson CL, Falkson G, Falkson HC. Improved results with the addition of Interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol. 1991;9:1403-1408.
123. Boddie AW Jr, Cangir A. Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma. Cancer. 1987;60:1720-1723.
124. Spitz S. Melanomas of childhood. Am J Pathol. 1948;24:591-609.
125. Allen AC, Spitz S. Malignant melanoma: a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1959;6:1-45.
126. Reintgen DS, Vollmer R, Seigler HF. Juvenile malignant melanoma. Surg Gynecol Obstet. 1989;168:249-253.
127. Chun K, Vazquez M, Sanchez JL. Malignant melanoma in children. Int J Dermatol. 1993;32:41-43.
128. Prose NS, Laude TA, Heilman ER, Coren C. Congenital malignant melanoma. Pediatrics. 1987;79:967-970.
129. Clark WH Jr, From L, Bernardine EA, et al. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29:705-726.
130. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172:902-908.
131. Balch CM, Murad TM, Soong SJ, et al. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg, 1978;188:732-742.
132. Crowley NJ, Seigler HF. Relationship between disease-free interval and survival in patients with recurrent melanoma. Arch Surg. 1992;127:1303-1308.
133. Heller R, Becker J, Wasselle J, et al. Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg. 1991;126:1455-1460.